Sartorius Stedim (France) Top Management

DIM Stock  EUR 192.75  0.90  0.47%   
Sartorius Stedim employs about 11.9 K people. The company is managed by 6 executives with a total tenure of roughly 27846 years, averaging almost 4641.0 years of service per executive, having 1989.0 employees per reported executive. Analysis of Sartorius Stedim's management performance can provide insight into the company performance.
Petra Kirchhoff  Insider
Head IR
Heiko Imhl  Insider
VP Relations
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Sartorius Stedim Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Sartorius Stedim Management Team Effectiveness

The company has return on total asset (ROA) of 0.1548 % which means that it generated a profit of $0.1548 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.4143 %, meaning that it generated $0.4143 on every $100 dollars invested by stockholders. Sartorius Stedim's management efficiency ratios could be used to measure how well Sartorius Stedim manages its routine affairs as well as how well it operates its assets and liabilities.

Sartorius Stedim Workforce Comparison

Sartorius Stedim Biotech is one of the top stocks in number of employees category among its peers. The total workforce of Medical Instruments & Supplies industry is currently estimated at about 12,019. Sartorius Stedim totals roughly 11,934 in number of employees claiming about 99% of all equities under Medical Instruments & Supplies industry.
The company has Profit Margin (PM) of 0.25 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.32 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.32.

Sartorius Stedim Biotech Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Sartorius Stedim Biotech Price Series Summation is a cross summation of Sartorius Stedim price series and its benchmark/peer.

Sartorius Stedim Notable Stakeholders

A Sartorius Stedim stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Sartorius Stedim often face trade-offs trying to please all of them. Sartorius Stedim's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Sartorius Stedim's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About Sartorius Stedim Management Performance

The success or failure of an entity such as Sartorius Stedim Biotech often depends on how effective the management is. Sartorius Stedim management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Sartorius management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Sartorius management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG. SARTORIUS STED operates under Medical Instruments Supplies classification in France and is traded on Paris Stock Exchange. It employs 10409 people.
Please note, the presentation of Sartorius Stedim's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sartorius Stedim's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Sartorius Stedim's management manipulating its earnings.

Sartorius Stedim Workforce Analysis

Traditionally, organizations such as Sartorius Stedim use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Sartorius Stedim within its industry.

Sartorius Stedim Manpower Efficiency

Return on Sartorius Stedim Manpower

Revenue Per Employee292.7K
Revenue Per Executive582.1M
Net Income Per Employee94.7K
Net Income Per Executive188.4M
Working Capital Per Employee10.2K
Working Capital Per Executive20.3M

Complementary Tools for Sartorius Stock analysis

When running Sartorius Stedim's price analysis, check to measure Sartorius Stedim's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sartorius Stedim is operating at the current time. Most of Sartorius Stedim's value examination focuses on studying past and present price action to predict the probability of Sartorius Stedim's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sartorius Stedim's price. Additionally, you may evaluate how the addition of Sartorius Stedim to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Valuation
Check real value of public entities based on technical and fundamental data